Literature DB >> 11436987

Role of heme oxygenase-1 and Kupffer cells in the production of bilirubin in the rat liver.

K Hirano1, T Kobayashi, T Watanabe, T Yamamoto, G Hasegawa, K Hatakeyama, M Suematsu, M Naito.   

Abstract

Heme oxygenase (HO)-1, the heme-degrading enzyme in macrophages, plays a key role in bilirubin metabolism. HO-1 is expressed in various tissue macrophages, especially Kupffer cells. This study aimed to examine the roles of macrophages and HO-1 in the modulation of heme catabolism in rat livers. Rats treated with or without liposome-encapsulated dichloromethylene diphosphonate, a macrophage-depleting reagent, were administered with heat-denatured red blood cells (h-RBC), and the time course of the biliary output of bilirubin and the expressions of HO-1 mRNA and protein were monitored. Immunohistochemistry in the control rat liver revealed that Kupffer cells constitute a major cellular component expressing HO-1, while hepatocytes exhibited little expression. The levels of HO-1 expression in Kupffer cells were elevated immediately after injection of h-RBC. In Kupffer cell-depleted livers, however, HO-1-expressing cells were not detected even after h-RBC administration. HO-1 mRNA levels were elevated at 2 h after administration of h-RBC in control rat livers, while they were very low in Kupffer cell-depleted rat livers. The control and Kupffer cell-depleted groups exhibited distinct time courses of biliary bilirubin excretion. In the untreated control rats, total bilirubin excretion increased about two-fold at 5 h after h-RBC administration. In contrast, the Kupffer cell-depleting treatment decreased the level of bilirubin production; administration of h-RBC to Kupffer cell-depleted rats did not accelerate the generation of bilirubin. These results suggest that Kupffer cells serve both as a sensor for scenesent RBC clearance and an effector that upregulates heme-degrading capacity and bilirubin production.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11436987     DOI: 10.1679/aohc.64.169

Source DB:  PubMed          Journal:  Arch Histol Cytol        ISSN: 0914-9465


  2 in total

1.  Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivo.

Authors:  Remco van Dijk; Sem J Aronson; Dirk R de Waart; Stan F van de Graaf; Suzanne Duijst; Jurgen Seppen; Ronald Oude Elferink; Ulrich Beuers; Piter J Bosma
Journal:  Sci Rep       Date:  2017-05-10       Impact factor: 4.379

2.  Haemoxygenase modulates cytokine induced neutrophil chemoattractant in hepatic ischemia reperfusion injury.

Authors:  Niteen Tapuria; Sameer Junnarkar; Mahmoud Abu-Amara; Barry Fuller; Alexander M Seifalian; Brian R Davidson
Journal:  World J Gastroenterol       Date:  2016-09-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.